On the first day of trading, the Hong Kong stock new issue HAIXI PHARMA opened high at 18%, reporting HKD 102
On its first day of trading, the Hong Kong stock of HAIXI PHARMA opened 18% higher, at HKD 102. HAIXI PHARMA was established on March 27, 2012, and is headquartered in Fuzhou, Fujian Province. It produces both generic drugs and has innovative drug pipelines under research, making it a pharmaceutical company in the commercialization stage. Its commercialized product portfolio mainly includes generic drugs for digestive system diseases, cardiovascular system diseases, endocrine system diseases, neurological diseases, and inflammatory diseases
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments